4
Changes in Ownership
Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-21-006787
EVP and Chief Medical Officer sold 2,243 shares at $140.36 ($314,827)
From the SEC's structured data for this filing
Trades in this filing
Bedrosian Camille L · EVP and Chief Medical Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-01-30 | Sale : show line 1 in the form | −2,243 | $140.36 | $314,827 | 33,546 | D |
| Open-market sales · 2,243 sh · avg $140.36 · $314,827 | ||||||
Loading xslF345X03/doc4.xml…